August 30, 2026
Hugel to enter ECM-based injectable market with aesthetic portfolio expansion
B Hugel secures the domestic sales rights for ECM-based injectable CellREDM, planning collaboration with Hans Biomed The company aims to create synergies with its botulinum…
